Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

Objective Although low infliximab trough concentrations and antibodies to infliximab (ATI) are associated with poor outcomes in patients with Crohn's disease (CD), the clinical relevance of ATI in ...

5245502d47422d31343133 Overview of Infliximab and Biosimilars Infliximab, marketed as Remicade, is a monoclonal antibody used to treat various autoimmune disorders, including rheumatoid arthritis ...

Two more women have been hospitalised with suspected botulism as another fights for life, with all three believed to have received unregulated anti-wrinkle injections from the same person.

It’s self-administered as a subcutaneous injection, either daily or three times a week. The newest DMTs are monoclonal antibodies. These treatments target specific molecules within the immune ...

Copyright 2025 The Associated Press. All Rights Reserved. In this undated photo provided by the South Carolina Department of Corrections, viewing chairs are placed in ...

The global remicade biosimilar market is projected to expand significantly between 2025 and 2035, with a market size growing from USD 2.32 billion in 2025 to USD 4.01 billion in 2035, at a robust ...

LAKEWOOD, Colo.--(BUSINESS WIRE)--Vivo Infusion, a nationally recognized provider of accessible and affordable ambulatory infusion services, announced today it has acquired the Neurology Institute ...